Literature DB >> 23846496

Acat1 gene ablation in mice increases hematopoietic progenitor cell proliferation in bone marrow and causes leukocytosis.

Li-Hao Huang1, Jingang Gui, Erika Artinger, Ruth Craig, Brent L Berwin, Patricia A Ernst, Catherine C Y Chang, Ta-Yuan Chang.   

Abstract

OBJECTIVE: To investigate the role of acyl-CoA:cholesterol acyltransferase 1 (ACAT1) in hematopoiesis. APPROACH AND
RESULTS: ACAT1 converts cellular cholesterol to cholesteryl esters for storage in multiple cell types and is a potential drug target for human diseases. In mouse models for atherosclerosis, global Acat1 knockout causes increased lesion size; bone marrow transplantation experiments suggest that the increased lesion size might be caused by ACAT1 deficiency in macrophages. However, bone marrow contains hematopoietic stem cells that give rise to cells in myeloid and lymphoid lineages; these cell types affect atherosclerosis at various stages. Here, we test the hypothesis that global Acat1(-/-) may affect hematopoiesis, rather than affecting macrophage function only, and show that Acat1(-/-) mice contain significantly higher numbers of myeloid cells and other cells than wild-type mice. Detailed analysis of bone marrow cells demonstrated that Acat1(-/-) causes a higher proportion of the stem cell-enriched Lin(-)Sca-1(+)c-Kit(+) population to proliferate, resulting in higher numbers of myeloid progenitor cells. In addition, we show that Acat1(-/-) causes higher monocytosis in Apoe(-/-) mouse during atherosclerosis development.
CONCLUSIONS: ACAT1 plays important roles in hematopoiesis in normal mouse and in Apoe(-/-) mouse during atherosclerosis development.

Entities:  

Keywords:  acyl-CoA cholesterol acyltransferase 1; atherosclerosis; leukocytosis; monocytes

Mesh:

Substances:

Year:  2013        PMID: 23846496      PMCID: PMC3882116          DOI: 10.1161/ATVBAHA.112.301080

Source DB:  PubMed          Journal:  Arterioscler Thromb Vasc Biol        ISSN: 1079-5642            Impact factor:   8.311


  21 in total

Review 1.  Signal transduction mediated by the Ras/Raf/MEK/ERK pathway from cytokine receptors to transcription factors: potential targeting for therapeutic intervention.

Authors:  F Chang; L S Steelman; J T Lee; J G Shelton; P M Navolanic; W L Blalock; R A Franklin; J A McCubrey
Journal:  Leukemia       Date:  2003-07       Impact factor: 11.528

2.  Localization of human acyl-coenzyme A: cholesterol acyltransferase-1 (ACAT-1) in macrophages and in various tissues.

Authors:  N Sakashita; A Miyazaki; M Takeya; S Horiuchi; C C Chang; T Y Chang; K Takahashi
Journal:  Am J Pathol       Date:  2000-01       Impact factor: 4.307

3.  Differential expression of ACAT1 and ACAT2 among cells within liver, intestine, kidney, and adrenal of nonhuman primates.

Authors:  R G Lee; M C Willingham; M A Davis; K A Skinner; L L Rudel
Journal:  J Lipid Res       Date:  2000-12       Impact factor: 5.922

Review 4.  Lipid rafts and signal transduction.

Authors:  K Simons; D Toomre
Journal:  Nat Rev Mol Cell Biol       Date:  2000-10       Impact factor: 94.444

Review 5.  Acyl coenzyme A: cholesterol acyltransferase types 1 and 2: structure and function in atherosclerosis.

Authors:  L L Rudel; R G Lee; T L Cockman
Journal:  Curr Opin Lipidol       Date:  2001-04       Impact factor: 4.776

Review 6.  Mammalian acyl-CoA:cholesterol acyltransferases.

Authors:  K F Buhman; M Accad; R V Farese
Journal:  Biochim Biophys Acta       Date:  2000-12-15

7.  A preliminary report: preparations containing Interleukin-3 (IL-3) promote proliferation of multipotential stem cells (CFUs) in the mouse.

Authors:  J M Garland; S Crompton
Journal:  Exp Hematol       Date:  1983-09       Impact factor: 3.084

8.  Increased atherosclerosis in LDL receptor-null mice lacking ACAT1 in macrophages.

Authors:  S Fazio; A S Major; L L Swift; L A Gleaves; M Accad; M F Linton; R V Farese
Journal:  J Clin Invest       Date:  2001-01       Impact factor: 14.808

9.  Acyl-coenzyme A:cholesterol acyltransferase 2 (ACAT2) is induced in monocyte-derived macrophages: in vivo and in vitro studies.

Authors:  Naomi Sakashita; Akira Miyazaki; Catherine C Y Chang; Ta-Yuan Chang; Emi Kiyota; Maki Satoh; Yoshihiro Komohara; Peter M Morganelli; Seikoh Horiuchi; Motohiro Takeya
Journal:  Lab Invest       Date:  2003-11       Impact factor: 5.662

10.  ACAT inhibition reduces the progression of preexisting, advanced atherosclerotic mouse lesions without plaque or systemic toxicity.

Authors:  James X Rong; Courtney Blachford; Jonathan E Feig; Ilda Bander; Jeffrey Mayne; Jun Kusunoki; Christine Miller; Matthew Davis; Martha Wilson; Shirley Dehn; Edward Thorp; Ira Tabas; Mark B Taubman; Lawrence L Rudel; Edward A Fisher
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-08       Impact factor: 8.311

View more
  13 in total

1.  Donor single nucleotide polymorphism in ACAT1 affects the incidence of graft-versus-host disease after bone marrow transplantation.

Authors:  Sonoko Kamoshita; Makoto Murata; Daisuke Koyama; Jakrawadee Julamanee; Shingo Okuno; Erina Takagi; Kotaro Miyao; Tatsunori Goto; Yukiyasu Ozawa; Koichi Miyamura; Seitaro Terakura; Tetsuya Nishida; Hitoshi Kiyoi
Journal:  Int J Hematol       Date:  2019-09-26       Impact factor: 2.490

Review 2.  Cholesterol and lipoprotein metabolism: Early Career Committee contribution.

Authors:  Hanrui Zhang; Ryan E Temel; Catherine Martel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-09       Impact factor: 8.311

3.  Myeloid-specific Acat1 ablation attenuates inflammatory responses in macrophages, improves insulin sensitivity, and suppresses diet-induced obesity.

Authors:  Li-Hao Huang; Elaina M Melton; Haibo Li; Paul Sohn; DaeYoung Jung; Ching-Yi Tsai; Tian Ma; Hiroyuki Sano; HyeKyung Ha; Randall H Friedline; Jason K Kim; Edward Usherwood; Catherine C Y Chang; Ta-Yuan Chang
Journal:  Am J Physiol Endocrinol Metab       Date:  2018-03-13       Impact factor: 4.310

4.  Uptake of HDL-cholesterol contributes to lipid accumulation in clear cell renal cell carcinoma.

Authors:  JungYeon Kim; Bonne Thompson; Sungwon Han; Yair Lotan; Jeffrey G McDonald; Jin Ye
Journal:  Biochim Biophys Acta Mol Cell Biol Lipids       Date:  2019-09-09       Impact factor: 4.698

Review 5.  Atherosclerosis.

Authors:  Hong Lu; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-03       Impact factor: 8.311

6.  Acyl-coenzyme A:cholesterol acyltransferase 1 - significance of single-nucleotide polymorphism at residue 526 and the role of Pro347 near the fifth transmembrane domain.

Authors:  Li-Hao Huang; Koji Nishi; Song Li; Thomas Ho; Ruhong Dong; Catherine C Y Chang; Ta-Yuan Chang
Journal:  FEBS J       Date:  2014-02-24       Impact factor: 5.542

7.  Myeloid Acyl-CoA:Cholesterol Acyltransferase 1 Deficiency Reduces Lesion Macrophage Content and Suppresses Atherosclerosis Progression.

Authors:  Li-Hao Huang; Elaina M Melton; Haibo Li; Paul Sohn; Maximillian A Rogers; Mary Jo Mulligan-Kehoe; Steven N Fiering; William F Hickey; Catherine C Y Chang; Ta-Yuan Chang
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

8.  Myeloid Acat1/Soat1 KO attenuates pro-inflammatory responses in macrophages and protects against atherosclerosis in a model of advanced lesions.

Authors:  Elaina M Melton; Haibo Li; Jalen Benson; Paul Sohn; Li-Hao Huang; Bao-Liang Song; Bo-Liang Li; Catherine C Y Chang; Ta-Yuan Chang
Journal:  J Biol Chem       Date:  2019-09-08       Impact factor: 5.157

Review 9.  ACAT1/SOAT1 as a therapeutic target for Alzheimer's disease.

Authors:  Yohei Shibuya; Catherine Cy Chang; Ta-Yuan Chang
Journal:  Future Med Chem       Date:  2015-12-15       Impact factor: 3.808

10.  Clinical significance of monocyte heterogeneity.

Authors:  Brian K Stansfield; David A Ingram
Journal:  Clin Transl Med       Date:  2015-02-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.